Aug. 4 at 7:21 PM
$LFMD From 5 years of past experience, these is what I see.
1. Before the company became profitable, short would drop the stock after earnings if there was a mixed call. meaning that if WS growth was weak (flat) it would go down 20% after the report. That ended last quarter after the Q1 call. WS, as long as it's flat or growing but generating a good cash flow, it's not an issue any more. I believe that this will be the case tomorrow and I am expecting a little grow in WS with better EBITDA. This is huge because the stock price action doesn't depend on WS any more an it's contribution is less every quarter.
2. The other problem was HIMS but since LifeMD became profitable and with also achieved operating leverage, this is no longer the case. LifeMD is finally running on it's own.
3. The biggest risk has always been federal regulations but they seem to be working in favor lately.
